Device Trial Radar · NCT04614402
Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System
Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Jan 15, 2021
Primary completion
Apr 20, 2023
Study completion Mar 15, 2028
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- First posted
- Nov 4, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter tricuspid valve repair.
Conditions
- Tricuspid Valve Insufficiency
Interventions
Edwards PASCAL Transcatheter Valve Repair SystemDevice
The Edwards PASCAL Valve Repair System is indicated for the percutaneous reconstruction of an insufficient tricuspid valve.
Edwards PASCAL Precision Transcatheter Valve Repair SystemDevice
The Edwards PASCAL Precision Valve Repair System is indicated for the percutaneous reconstruction of an insufficient tricuspid valve.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with major adverse events (MAE rates)Time frame: 30 days
- Change in tricuspid regurgitation severity (scale of 0-5) by echocardiographyTime frame: Discharge: defined as discharge or 7 days post-procedure, whichever comes first
Locations
15 sites in 4 countries. Site status is shown where the registry gives one.
UKE Hamburg
Hamburg, Germany
Kath. Marienkrankenhaus Hamburg gGmbH
Hamburg, Germany
University Heart Center Lübeck
Lübeck, Germany
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.